Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148942014> ?p ?o ?g. }
- W2148942014 endingPage "1" @default.
- W2148942014 startingPage "1" @default.
- W2148942014 abstract "The increasing prevalence of resistance to established antibiotics among key bacterial respiratory tract pathogens, such as Streptococcus pneumoniae, is a major healthcare problem in the USA. The PROTEKT US study is a longitudinal surveillance study designed to monitor the susceptibility of key respiratory tract pathogens in the USA to a range of commonly used antimicrobials. Here, we assess the geographic and temporal trends in antibacterial resistance of S. pneumoniae isolates from patients with community-acquired respiratory tract infections collected between Year 1 (2000–2001) and Year 4 (2003–2004) of PROTEKT US. Antibacterial minimum inhibitory concentrations were determined centrally using the Clinical and Laboratory Standards Institute (CLSI) broth microdilution method; susceptibility was defined according to CLSI interpretive criteria. Macrolide resistance genotypes were determined by polymerase chain reaction. A total of 39,495 S. pneumoniae isolates were collected during 2000–2004. The percentage of isolates resistant to erythromycin, penicillin, levofloxacin, and telithromycin were 29.3%, 21.2%, 0.9%, and 0.02%, respectively, over the 4 years, with marked regional variability. The proportion of isolates exhibiting multidrug resistance (includes isolates known as penicillin-resistant S. pneumoniae and isolates resistant to ≥ 2 of the following antibiotics: penicillin; second-generation cephalosporins, e.g. cefuroxime; macrolides; tetracyclines; and trimethoprim-sulfamethoxazole) remained stable at ~30% over the study period. Overall mef(A) was the most common macrolide resistance mechanism. The proportion of mef(A) isolates decreased from 68.8% to 62.3% between Year 1 and Year 4, while the percentage of isolates carrying both erm(B) and mef(A) increased from 9.7% to 18.4%. Over 99% of the erm(B)+mef(A)-positive isolates collected over Years 1–4 exhibited multidrug resistance. Higher than previously reported levels of macrolide resistance were found for mef(A)-positive isolates. Over the first 4 years of PROTEKT US, penicillin and erythromycin resistance among pneumococcal isolates has remained high. Although macrolide resistance rates have stabilized, the prevalence of clonal isolates, with a combined erm(B) and mef(A) genotype together with high-level macrolide and multidrug resistance, is increasing, and their spread may have serious health implications. Telithromycin and levofloxacin both showed potent in vitro activity against S. pneumoniae isolates irrespective of macrolide resistance genotype." @default.
- W2148942014 created "2016-06-24" @default.
- W2148942014 creator A5019407143 @default.
- W2148942014 creator A5037843249 @default.
- W2148942014 creator A5069366221 @default.
- W2148942014 date "2008-01-01" @default.
- W2148942014 modified "2023-10-16" @default.
- W2148942014 title "Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1–4" @default.
- W2148942014 cites W190526261 @default.
- W2148942014 cites W1925363657 @default.
- W2148942014 cites W1973209498 @default.
- W2148942014 cites W1974070554 @default.
- W2148942014 cites W1974175819 @default.
- W2148942014 cites W1981627893 @default.
- W2148942014 cites W1987330843 @default.
- W2148942014 cites W1989199187 @default.
- W2148942014 cites W1989219826 @default.
- W2148942014 cites W1989983346 @default.
- W2148942014 cites W2005334676 @default.
- W2148942014 cites W2012722858 @default.
- W2148942014 cites W2013758955 @default.
- W2148942014 cites W2017865746 @default.
- W2148942014 cites W2018541880 @default.
- W2148942014 cites W2020483434 @default.
- W2148942014 cites W2028987338 @default.
- W2148942014 cites W2035250264 @default.
- W2148942014 cites W2036066753 @default.
- W2148942014 cites W2054525646 @default.
- W2148942014 cites W2068774315 @default.
- W2148942014 cites W2073497999 @default.
- W2148942014 cites W2079603390 @default.
- W2148942014 cites W2079712827 @default.
- W2148942014 cites W2084774709 @default.
- W2148942014 cites W2084883112 @default.
- W2148942014 cites W2086660656 @default.
- W2148942014 cites W2091152656 @default.
- W2148942014 cites W2097667778 @default.
- W2148942014 cites W2100059020 @default.
- W2148942014 cites W2102115200 @default.
- W2148942014 cites W2104346641 @default.
- W2148942014 cites W2108707230 @default.
- W2148942014 cites W2115071132 @default.
- W2148942014 cites W2116974058 @default.
- W2148942014 cites W2119862730 @default.
- W2148942014 cites W2120987483 @default.
- W2148942014 cites W2121706914 @default.
- W2148942014 cites W2122854053 @default.
- W2148942014 cites W2123324969 @default.
- W2148942014 cites W2123899780 @default.
- W2148942014 cites W2131240319 @default.
- W2148942014 cites W2133979383 @default.
- W2148942014 cites W2135916784 @default.
- W2148942014 cites W2137532164 @default.
- W2148942014 cites W2138445568 @default.
- W2148942014 cites W2145680222 @default.
- W2148942014 cites W2147307982 @default.
- W2148942014 cites W2159004468 @default.
- W2148942014 cites W2161859251 @default.
- W2148942014 cites W2165667261 @default.
- W2148942014 cites W2171728511 @default.
- W2148942014 cites W303883530 @default.
- W2148942014 doi "https://doi.org/10.1186/1476-0711-7-1" @default.
- W2148942014 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2262084" @default.
- W2148942014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18190701" @default.
- W2148942014 hasPublicationYear "2008" @default.
- W2148942014 type Work @default.
- W2148942014 sameAs 2148942014 @default.
- W2148942014 citedByCount "139" @default.
- W2148942014 countsByYear W21489420142012 @default.
- W2148942014 countsByYear W21489420142013 @default.
- W2148942014 countsByYear W21489420142014 @default.
- W2148942014 countsByYear W21489420142015 @default.
- W2148942014 countsByYear W21489420142016 @default.
- W2148942014 countsByYear W21489420142017 @default.
- W2148942014 countsByYear W21489420142018 @default.
- W2148942014 countsByYear W21489420142020 @default.
- W2148942014 countsByYear W21489420142021 @default.
- W2148942014 countsByYear W21489420142022 @default.
- W2148942014 countsByYear W21489420142023 @default.
- W2148942014 crossrefType "journal-article" @default.
- W2148942014 hasAuthorship W2148942014A5019407143 @default.
- W2148942014 hasAuthorship W2148942014A5037843249 @default.
- W2148942014 hasAuthorship W2148942014A5069366221 @default.
- W2148942014 hasBestOaLocation W21489420141 @default.
- W2148942014 hasConcept C114851261 @default.
- W2148942014 hasConcept C126322002 @default.
- W2148942014 hasConcept C174802600 @default.
- W2148942014 hasConcept C176947019 @default.
- W2148942014 hasConcept C2776012195 @default.
- W2148942014 hasConcept C2777514703 @default.
- W2148942014 hasConcept C2779425571 @default.
- W2148942014 hasConcept C2780206985 @default.
- W2148942014 hasConcept C2780728791 @default.
- W2148942014 hasConcept C2780950330 @default.
- W2148942014 hasConcept C2781253189 @default.
- W2148942014 hasConcept C2781276175 @default.
- W2148942014 hasConcept C501593827 @default.
- W2148942014 hasConcept C534529494 @default.